Brief Report: Suspected Cannabis-Induced Mania and Psychosis in Young Adult Males with Autism Spectrum Disorder.
Daily cannabis may spark mania or psychosis in autistic young men—screen and monitor closely.
01Research in Context
What this study did
Majd et al. (2022) tracked three autistic young men who used cannabis every day.
Doctors wrote up each case to see if the drug linked to new mania or psychosis.
What they found
All three users developed mania or psychotic episodes soon after starting steady cannabis.
The cases hint that autistic young adults may react badly to THC or CBD products.
How this fits with other research
Delgado-Lobete et al. (2019) showed autistic youth already struggle to get mental-health care.
So et al. (2021) added that autistic teens in crisis carry high suicide risk.
Together the papers paint the same picture: this group is psychiatrically fragile.
Fyke et al. (2021) saw that mice missing CB1 receptors act more autistic.
That lab finding and these human cases both flag the cannabinoid system—but one shows lack of CB1 hurts social skills, while the other shows flooding CB1 with THC can trigger psychosis.
The studies do not clash; they simply map opposite ends of the same biology.
Why it matters
Before you sign off on a medical-cannabis plan, screen for any mood or psychosis history.
Warn families that even legal CBD oils could tip an autistic young adult into mania.
Document use and watch for sleeplessness, racing speech, or odd beliefs.
If those signs appear, stop the product and get emergency psychiatric help fast.
Want CEUs on This Topic?
The ABA Clubhouse has 60+ free CEUs — live every Wednesday. Ethics, supervision & clinical topics.
Join Free →Add one question about cannabis use to your intake form and share the risk note with parents.
02At a glance
03Original abstract
There is increasing interest in investigating cannabis for behavioral symptoms in individuals with autism spectrum disorder (ASD). The potential role of dysregulated cannabinoid signaling contributing to the pathophysiology of ASD is an area of active investigation. Results from retrospective and uncontrolled trials of cannabis in subjects with ASD have been published, reporting both potential benefits and adverse effects. Here, we describe the clinical course of three young adult males with ASD who developed mania or psychosis after the consistent use of cannabidiol and delta-9-tetrahydrocannabinol. Caution should be utilized with cannabis use in individuals with ASD until large-scale, replicated randomized controlled trials demonstrating efficacy, safety and tolerability have been published.
Journal of autism and developmental disorders, 2022 · doi:10.3390/ijms18091916